2018
DOI: 10.1111/resp.13280
|View full text |Cite
|
Sign up to set email alerts
|

Bronchiectasis in indigenous and non‐indigenous residents of Australia and New Zealand

Abstract: Bronchiectasis is not one disease. It has a significant impact on healthcare utilization and survival. Differences between populations are likely to relate to differing aetiologies and understanding the drivers of bronchiectasis in disadvantaged populations will be key.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
81
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 52 publications
(82 citation statements)
references
References 22 publications
0
81
1
Order By: Relevance
“…Crucially, our lung function data are in stark contrast to that reported recently in Indigenous Australian and New Zealand adults with bronchiectasis 31 . In the aforementioned study, Indigenous adults from Central Australia with bronchiectasis (a region where 31/131 [23.6%] of our cohort resided) were relatively young (mean age = 43.7 [SD: 12.3] years), had poor lung function (median FEV 1% predicted = 30% [IQR: 42.8‐65.7]) and died prematurely (median age = 50.1 years [IQR: 41.8‐54.6]) 31 . The Indigenous New Zealand cohort within the same study had a mean age of 58.2 (SD: 15.2) years, median FEV 1 % predicted = 42% (IQR: 31.0‐56.0), and median age of death = 70.8 (IQR: 60.4‐76.6) years 31 .…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…Crucially, our lung function data are in stark contrast to that reported recently in Indigenous Australian and New Zealand adults with bronchiectasis 31 . In the aforementioned study, Indigenous adults from Central Australia with bronchiectasis (a region where 31/131 [23.6%] of our cohort resided) were relatively young (mean age = 43.7 [SD: 12.3] years), had poor lung function (median FEV 1% predicted = 30% [IQR: 42.8‐65.7]) and died prematurely (median age = 50.1 years [IQR: 41.8‐54.6]) 31 . The Indigenous New Zealand cohort within the same study had a mean age of 58.2 (SD: 15.2) years, median FEV 1 % predicted = 42% (IQR: 31.0‐56.0), and median age of death = 70.8 (IQR: 60.4‐76.6) years 31 .…”
Section: Discussioncontrasting
confidence: 99%
“…In the aforementioned study, Indigenous adults from Central Australia with bronchiectasis (a region where 31/131 [23.6%] of our cohort resided) were relatively young (mean age = 43.7 [SD: 12.3] years), had poor lung function (median FEV 1% predicted = 30% [IQR: 42.8‐65.7]) and died prematurely (median age = 50.1 years [IQR: 41.8‐54.6]) 31 . The Indigenous New Zealand cohort within the same study had a mean age of 58.2 (SD: 15.2) years, median FEV 1 % predicted = 42% (IQR: 31.0‐56.0), and median age of death = 70.8 (IQR: 60.4‐76.6) years 31 . Rather than assuming these data reflect an age cohort effect, they highlight the need to understand the reasons for deteriorating lung health and function between adolescence and adulthood in these vulnerable populations.…”
Section: Discussionmentioning
confidence: 99%
“…1 Regarding chronic respiratory illnesses, the disparity between Aboriginal and non-Aboriginal patients with bronchiectasis is particularly marked. 2 A recent study reported that the average age of death in patients with bronchiectasis was 22 years younger in…”
Section: What This Paper Addsmentioning
confidence: 99%
“…Respiratory illnesses account for 12% of the age‐standardised gap in mortality between Aboriginal and other Australians . Regarding chronic respiratory illnesses, the disparity between Aboriginal and non‐Aboriginal patients with bronchiectasis is particularly marked . A recent study reported that the average age of death in patients with bronchiectasis was 22 years younger in Aboriginal patients than non‐Aboriginal patients .…”
mentioning
confidence: 99%
See 1 more Smart Citation